Nang Kuang Pharmaceutical Co., Ltd.

TWSE:1752 Stock Report

Market Cap: NT$4.8b

Nang Kuang Pharmaceutical Balance Sheet Health

Financial Health criteria checks 6/6

Nang Kuang Pharmaceutical has a total shareholder equity of NT$2.2B and total debt of NT$395.0M, which brings its debt-to-equity ratio to 17.7%. Its total assets and total liabilities are NT$3.6B and NT$1.4B respectively. Nang Kuang Pharmaceutical's EBIT is NT$224.2M making its interest coverage ratio -97.2. It has cash and short-term investments of NT$228.1M.

Key information

17.7%

Debt to equity ratio

NT$395.00m

Debt

Interest coverage ratio-97.2x
CashNT$228.09m
EquityNT$2.23b
Total liabilitiesNT$1.37b
Total assetsNT$3.60b

Recent financial health updates

Recent updates

Nang Kuang Pharmaceutical Co., Ltd.'s (TWSE:1752) 28% Price Boost Is Out Of Tune With Earnings

May 22
Nang Kuang Pharmaceutical Co., Ltd.'s (TWSE:1752) 28% Price Boost Is Out Of Tune With Earnings

Some Investors May Be Willing To Look Past Nang Kuang Pharmaceutical's (TWSE:1752) Soft Earnings

Apr 02
Some Investors May Be Willing To Look Past Nang Kuang Pharmaceutical's (TWSE:1752) Soft Earnings

Nang Kuang Pharmaceutical (GTSM:1752) Has A Pretty Healthy Balance Sheet

Mar 20
Nang Kuang Pharmaceutical (GTSM:1752) Has A Pretty Healthy Balance Sheet

Should You Or Shouldn't You: A Dividend Analysis on Nang Kuang Pharmaceutical Co., Ltd. (GTSM:1752)

Mar 03
Should You Or Shouldn't You: A Dividend Analysis on Nang Kuang Pharmaceutical Co., Ltd. (GTSM:1752)

Declining Stock and Decent Financials: Is The Market Wrong About Nang Kuang Pharmaceutical Co., Ltd. (GTSM:1752)?

Feb 13
Declining Stock and Decent Financials: Is The Market Wrong About Nang Kuang Pharmaceutical Co., Ltd. (GTSM:1752)?

Nang Kuang Pharmaceutical's (GTSM:1752) Stock Price Has Reduced 17% In The Past Five Years

Jan 26
Nang Kuang Pharmaceutical's (GTSM:1752) Stock Price Has Reduced 17% In The Past Five Years

Estimating The Fair Value Of Nang Kuang Pharmaceutical Co., Ltd. (GTSM:1752)

Jan 08
Estimating The Fair Value Of Nang Kuang Pharmaceutical Co., Ltd. (GTSM:1752)

Here's How We Evaluate Nang Kuang Pharmaceutical Co., Ltd.'s (GTSM:1752) Dividend

Nov 29
Here's How We Evaluate Nang Kuang Pharmaceutical Co., Ltd.'s (GTSM:1752) Dividend

Financial Position Analysis

Short Term Liabilities: 1752's short term assets (NT$1.4B) exceed its short term liabilities (NT$1.2B).

Long Term Liabilities: 1752's short term assets (NT$1.4B) exceed its long term liabilities (NT$196.8M).


Debt to Equity History and Analysis

Debt Level: 1752's net debt to equity ratio (7.5%) is considered satisfactory.

Reducing Debt: 1752's debt to equity ratio has reduced from 19.6% to 17.7% over the past 5 years.

Debt Coverage: 1752's debt is well covered by operating cash flow (106%).

Interest Coverage: 1752 earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.